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down-regulated IL-8 and MCP-1 mRNA and also inhibitedShiga toxin-2 triggers endothelial leukocyte adhesion and trans-
the adhesion and transmigration of leukocytes in Stx-treatedmigration via NF-B dependent up-regulation of IL-8 and
HUVEC.MCP-1.
Conclusions. Stx-2 via a transcriptional activation mecha-Background. Shiga toxin (Stx)-producing E. coli is a caus-
nism specifically mediated by NF-B up-regulates endothelialative agent of the epidemic form of hemolytic uremic syndrome
(HUS), the most common cause of acute renal failure in chil- MCP-1 and IL-8. Both chemokines are important modulators
dren. Endothelial injury and leukocyte activation are instru- of leukocyte adhesion and transmigration under flow. These
mental to the development of microangiopathic lesions. To findings might be relevant to understand the nature of micro-
obtain more insight into the mechanisms favoring endothelium- vascular lesions in HUS and open future perspectives for better
leukocyte interaction, we studied (1) the effect of Stx-2 on treatment of microvascular thrombosis.
leukocyte adhesion and transmigration in human endothelial
cells under flow; (2) the effect of Stx-2 on endothelial expres-
sion of monocyte chemoattractant protein-1 (MCP-1) and in-
Sporadic hemolytic uremic syndrome (HUS) is a dis-terleukin-8 (IL-8) and their functional role in the adhesive
phenomena; and (3) the role of nuclear factor-B (NF-B) in ease of thrombocytopenia, microangiopathic hemolytic
endothelial chemokine expression. anemia and acute renal failure that mainly affects infants
Methods. For adhesion experiments, human umbilical vein and small children [1, 2]. Infection with Shiga toxin (Stx)-endothelial cells (HUVEC) and human glomerular endothelial
producing Escherichia coli has been strongly implicatedcells (GEC) were incubated for 24 hours with Stx-2 (25 pmol/L),
with or without anti-IL-8 or MCP-1 antibodies, and then ex- as the most common causative agent [3–6]. E. coli
posed to leukocyte suspension under flow (1.5 dynes/cm2). IL-8 0157:H7 strains that are isolated from patients with HUS
and MCP-1 expression was evaluated in Stx-2 treated endothe- produce Stx-1 and Stx-2, and epidemiological data indi-lial cells (6 hours) by Northern blot. NF-B activity was as-
cate that Stx-2 producing E. coli are more likely to causesessed by electrophoretic mobility shift assay. The role of
HUS than the strains that produce only Stx-1 [5, 6].NF-B in Stx-induced chemokines was evaluated by transfect-
ing HUVEC with an adenovirus coding for IB. After the ingestion of contaminated food or water [7],
Results. Stx-2 significantly enhanced the number of leuko- Shiga toxins gain access to the systemic circulation and
cytes that adhered and then migrated across the endothelium.
rapidly and completely bind to specific receptors ex-Stx-2 increased the expression of IL-8 and MCP-1, which was
pressed on circulating cells, mainly polymorphonuclearpreceded by NF-B activation. Blocking of endothelial IL-8
and MCP-1 with corresponding antibodies significantly inhib- leukocytes, which transport them to the kidney or other
ited Stx-induced leukocyte adhesion and migration either in target organs [8, 9]. Endothelial damage is crucial to the
HUVEC or GEC. Adenovirus-mediated gene transfer of IB subsequent development of microangiopathic lesions,
and evidence is available that the interaction between
1 See Editorial by Siegler and Pysher, p. 1088. leukocytes and endothelial cells serves to magnify the ex-
tent of endothelial injury [5, 6, 10, 11]. Shiga toxins canKey words: hemolytic uremic syndrome, chemokines, glomerular endo-
thelial cells, gene transfer, flow, thrombocytopenia, acute renal failure. directly damage endothelial cells after binding to a spe-
cific glycosphingolipid globotriaosyl ceramide (Gb3) re-
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synthesis [4, 13, 14] and apoptosis [15]. Cytokines like METHODS
interleukin-1 (IL-1) and tumor necrosis factor (TNF) Endothelial cell culture and incubation
released by monocytes/macrophages in response to Stxs Human umbilical vein endothelial cells (HUVEC)
[16] remarkably enhanced vascular sensitivity to the tox- were obtained by collagenase digestion according to the
ins by up-regulating the endothelial Gb3 receptor [13]. method of Jaffe´ et al [26]. The cells were grown in Me-
We have demonstrated that Stx-1 induced a massive dium 199 (Gibco BRL, Gaithersburg, MD, USA) sup-
leukocyte adhesion to cultured human endothelial cells un- plemented with 10% newborn calf serum (Gibco) and
der flow conditions, by up-regulating the adhesive proteins 10% human serum, 5 mmol/L N-2-hydroxyethylpipera-
E-selectin, intracellular adhesion molecule-1 (ICAM-1), zine-N-2-ethanesulfonic acid (HEPES; Sigma Chemical,
and vascular cell adhesion molecule-1 (VCAM-1) [17]. St. Louis, MO, USA), 100 U/mL penicillin, 100 g/mL
The adhesion of leukocytes was enhanced by pre-expo- streptomycin, 2.5 g/mL fungizone, 2 mmol/L glutamine
sure of the endothelial cells to TNF-. Moreover, neutro- (Gibco), 15 U/mL heparin (Parke-Davis, Milan, Italy)
phils from children with the acute phase of HUS adhered and 50 g/mL endothelial cell growth factor. Cultured
to endothelial cells in vitro more than normal neutrophils cells were identified as endothelial by their cobblestone
and induced endothelial injury by local release of prote- morphology and the presence of von Willebrand factor,
ases [18]. Indeed, plasma concentrations of 1-antitryp- using indirect immunofluorescence microscopy. Conflu-
sin–complexed elastase and the chemokine IL-8—a po- ent cells were routinely used between the first and fifth
tent activator of neutrophils—were remarkably higher in passages. For adhesion experiments, HUVEC were plated
the acute phase of the disease, which presumably reflected on 60  20 mm plastic coverslips (Thermanox; Nunc Inc.,
neutrophil activation and degranulation in vivo [19]. Naperville, IL, USA) coated with bovine gelatin (0.2%,
Kidney specimens from HUS children with evidence Sigma) and used two days after reaching confluence.
of Stx-producing E. coli infection revealed a conspicuous Human glomerular endothelial cells (GEC) were iso-
infiltration of polymorphonuclear and mononuclear cells lated from kidneys that were not suitable for transplanta-
within the glomeruli, along with microvascular injury tion because of anatomical anomalies or technical rea-
[20, 21]. In those patients urinary levels of IL-8 and sons, by collagenase digestion as previously described [27].
monocyte chemoattractant protein-1 (MCP-1), potent The cells were grown in Medium 199 supplemented with
attractants of neutrophils, and monocytes/macrophages 10% newborn calf serum (Gibco) and 10% human serum,
and T-lymphocytes, respectively, were elevated during 2 mmol/L glutamine, 100 U/mL penicillin, 100 g/mL
the acute phase of the disease, and gradually declined streptomycin, 5 U/mL heparin and 150 g/mL endothelial
until recovery, implying a role for these chemokines in cell growth factor. Cells were characterized by indirect
the recruitment of inflammatory cells at the glomerular immunofluorescence with a panel of endothelial cell-spe-
level [21, 22]. cific antibodies, namely von Willebrand factor, platelet-
Evidence is available that IL-8 and MCP-1 can be endothelial cell adhesion molecule-1 (PECAM-1) and
released by endothelial cells stimulated by proinflam- visceral epithelial (VE)-cadherin. To exclude contamina-
matory mediators, such as cytokines and lipopolysaccha- tion with epithelial and mesangial cells, indirect immuno-
ride [23], depending on the activity of the transcription fluorescence with antibodies against anti-cytokeratin 20
factor NF-B [24]. NF-B is present in an inactive form and anti--smooth muscle actin were performed [27].
in the cell cytoplasm and is activated upon proteolytic No immunoreactivity was observed in cells used for the
degradation of the inhibitory protein IB [25]. experiments, indicating that pure GEC were used. Two
The present study investigated: (1) the effects of Stx-2 different donors of GEC were used to perform experi-
on leukocyte adhesion and transmigration through hu- ments.
man endothelium human umbilical vein endothelial cells For adhesion experiments GEC were plated on 60 
(HUVEC) and human glomerular endothelial cells (GEC)- 20-mm plastic coverslips (Thermanox) coated with por-
under flow conditions; (2) the ability of Stx-2 to modulate cine gelatin (1%; Fluka BioChemika, Buchs, Switzer-
the endothelial expression of the chemoattractant pro- land) and used two days after reaching confluence.
teins IL-8 and MCP-1 and their functional role in the adhe- To investigate the effect of Stx-2 on leukocyte adhe-
sive phenomena. Moreover, since IL-8 and MCP-1 are sion and transmigration, confluent HUVEC were incu-
regulated by the transcription factor NF-B, we also stud- bated for 24 hours with medium alone (M-199 plus 10%
ied (3) whether Stx-2 induced the activation of NF-B fetal calf serum; Gibco), with Stx-2 at a subtoxic concen-
in endothelial cells and (4) whether transfection of endo- tration (25 pmol/L; Toxin Technology Inc., Sarasota, FL,
thelium with recombinant adenovirus coding for IB, USA) or with TNF- (100 U/mL; Knoll AG, Ludwigs-
the natural inhibitor of NF-B, resulted in successful hafen, Germany), then endothelial cells were perfused
inhibition of chemokine up-regulation, and leukocyte at 1.5 dynes/cm2 in a parallel plate flow chamber with
total leukocyte suspension. Selected adhesion experi-adhesion and transmigration induced by Stx-2.
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ments (N  3) under flow were performed in GEC ex- graphically (DEAE-anion exchange, Sephacryl-gel filtra-
tion). Purity was assessed using sodium dodecyl saline-posed for 24 hours to Stx-2 (25 pmol/L).
To elucidate whether Stx-2 modulated endothelial ex- polyacrylamide gel electrophoresis (SDS-PAGE) and ac-
tivity was determined by a Vero cells-cytotoxicity assay.pression of IL-8 and MCP-1, HUVEC were exposed for
six hours to different concentrations of Stx-2 (25 pmol/L,
Leukocyte isolation50 pmol/L and 1 nmol/L), and then cells were processed
for Northern blot analysis of IL-8 and MCP-1 mRNA. Leukocyte suspension was prepared from human fresh
venous blood collected from healthy volunteers on ethyl-The role of these chemokines in Stx-induced leukocyte
adhesion and transmigration was evaluated by incubat- enediaminetetraacetic acid (EDTA; final concentration
5 mmol/L) and diluted with an equal volume of colding HUVEC or GEC pre-treated 24 hours with 25
pmol/L Stx-2- with functional blocking rabbit polyclonal saline solution as previously described [17]. The blood
samples were centrifuged at 200  g for 10 minutes atanti-human IL-8 antibody (10 g/200 L; Endogen, Wo-
burn, MA, USA) or mouse monoclonal anti-human 4C, the cell pellet was resuspended in 4 volumes of
Emagel (Behringwerke AG, Marburg, Germany) andMCP-1 antibody (20 g/200 L; a kind gift by G. Peri,
Mario Negri Institute, Milan, Italy) [28] or with rabbit erythrocytes were allowed to sediment at 4C for 40
minutes. Supernatant was removed, centrifuged at 500or mouse isotype-matched IgG (10 g/200 L, Endogen;
and 20 g/200 L, Camfolio, Becton Dickinson, San g for 10 minutes at 4C and the pellet washed twice by
centrifugation with saline. The remaining erythrocytesJose, CA, respectively) as control, for 20 minutes at room
temperature, before the adhesion assay. were removed by ammonium chloride lysis at 4C and
centrifugation. After this procedure the cell viability,To identify the leukocyte populations that adhered on
Stx-treated endothelial cells in the presence or absence measured by trypan blue exclusion, was greater than
95%. Cells were then resuspended in culture medium atof anti-IL-8 and MCP-1 antibodies, HUVEC at the end
of leukocyte perfusion under flow were stained by May- a final concentration of 106 cells/mL.
Grunwald/Giemsa. Cells were fixed in methyl alcohol
Adhesion assay under flow conditionsfor three minutes at room temperature and stained with
1:2 dilution of May-Grunwald solution in phosphate- For adhesion experiments we used a parallel-plate
flow chamber and a perfusion system as previously de-buffered saline (PBS) for one minute. After two wash-
ings with distilled water, cells were incubated for five scribed [30, 31]. Briefly, the chamber is composed of two
parallel surfaces, a coverslip coated with HUVEC atminutes with 1:3 dilution of Giemsa solution in PBS.
Coverslips were washed twice and examined by micro- confluence and a flat surface machined from polymethyl-
methacrylate. The two surfaces are separated by ascope. Polymorphonuclear cells and mononuclear cells
were identified and counted in several fields (N  10) 250 m thick silicon rubber gasket, leaving a rectangular
surface of 30  13 mm exposed to flow. An inlet andfor each coverslip (N  4 experiments).
The ability of Stx-2 to activate the transcription factor outlet channel distributed the fluid uniformly along the
entrance side of the adhesion surface. Shear stress levelsNF-B was evaluated by electrophoretic mobility shift
analysis (EMSA) of nuclear extracts from HUVEC ex- as a function of medium flow rate was calculated assum-
ing fully developed laminar flow between the two parallelposed for one hour to Stx-2 (25 pmol/L, 50 pmol/L and
1 nmol/L). plates. After assembling with the HUVEC monolayer,
the chamber is placed on the stage of an inverted phase-Finally, to assess the involvement of NF-B in Stx-
induced IL-8 and MCP-1 mRNA up-regulation and leu- contrast microscope with a thermostated hood to main-
tain the temperature at 37C. The microscope is con-kocyte adhesion and transmigration, HUVEC were
transfected (for 3 h) with recombinant adenovirus coding nected with a video recording system (Panasonic, Osaka,
Japan). Leukocyte suspension was pumped through thefor IB, the natural inhibitor of NF-B [29]. After
transfection, cells were maintained for 24 hours in growth chamber, at controlled flow rates, using a syringe pump
(Harvard Apparatus Inc., South Natick, MA, USA).medium and then exposed (6 h) to 50 pmol/L Stx-2 for
Northern blot experiments or to 25 pmol/L Stx-2 (24 h) After initial perfusion with cell free medium plus 0.5%
bovine serum albumin at 0.6 dynes/cm2 for two minutesfor adhesion experiments.
for equilibration, the leukocyte suspension was perfused
Shiga toxin-2 preparation through the chamber at 1.5 dynes/cm2 and images re-
corded thereafter. After 10 minutes, cell free mediumShiga toxin-2 was prepared by the manufacturer as
follows: E. coli strain PMJ-100 was grown overnight in was perfused at a flow rate of 3.0 dynes/cm2 for evaluation
of the number of leukocytes rolling on the HUVECBrain Heart Infusion Broth, then centrifuged to collect
the cells. The cells were extracted by freezing and then surface. At this flow rate the rolling leukocytes are easily
distinguishable from cells freely flowing in the suspen-treating with lysing agent (B-PER; Pierce, Rockford, IL,
USA). The extract was dialyzed and purified chromato- sion that move much faster. After three minutes of perfu-
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sion at 3.0 dynes/cm2 several fields (10) were observed inhibitor cocktail tablets; Boehringer Mannheim, Mann-
heim, Germany). The protein concentration was deter-for evaluation of the number of firmly adherent cells.
Images acquired during the perfusion experiments were mined by the Bradford assay using the Bio-Rad protein
assay reagent.digitized and processed on a personal computer using
general purpose image processing software (NIH Image, Electrophoretic mobility shift and supershift assays.
Electrophoretic mobility shift assays (EMSAs) were per-v. 1.59; NIH, Bethesda, MD, USA). Adherent leukocytes
were identified and counted at the end of the 13 minute formed as previously described [36] using the kB DNA
sequence of the immunoglobulin gene (5-GGGACTperfusion, as previously described in details [31]. The
number of cells transmigrated across the HUVEC mono- TTCC). Nuclear extracts (2 g) were incubated with
50 kcpm of 32P labeled NF-B oligonucleotide in a bind-layer during the perfusion experiments was quantified
by visual inspection of the videotape, since adherent cells ing reaction mixture [10 mmol/L Tris-HCl, pH 7.5, 80
mmol/L NaCl, 1 mmol/L EDTA, 1 mmol/L dithiothreitolthat transmigrate under the endothelium change their
color from white to black [32]. (DTT), 5% glycerol, 1.5 g of poly(dI-dC)] for 30 min-
utes on ice. To assay the specificity of the binding reac-The shear stress of 1.5 dynes/cm2, used to study leuko-
cyte–endothelium interaction, mimics post-capillary ven- tion, a 100-fold molar excess of unlabeled NF-B probe
or an unlabeled nonspecific oligonucleotide (tissue plas-ule circulation [30], but this same value of wall shear
stress may be present also within the glomerular micro- minogen activator regulatory element, TRE) was added
to the binding reaction mixture as indicated, prior to thecirculation. In a three-dimensional model of glomerular
capillary [33], we estimated that a large fraction of glo- addition of the labeled B probe. For supershift assays,
the reaction mixture minus the probe was incubated formerular capillary segments are exposed to wall shear
stress values 	5 dynes/cm2. one hour on ice with 1 L of affinity-purified rabbit poly-
clonal antisera specific for p65 (sc-109), p50 (sc-114),
Northern blot analysis RelB (sc-226), cRel (sc-71) and p52 (sc-298; Santa Cruz
Biotechnology, Santa Cruz, CA, USA). The labeledTotal RNA was isolated from HUVEC by the guanid-
ium isothiocyanate/cesium chloride procedure, as pre- NF-B oligonucleotide was then added, and the incuba-
tion was continued at room temperature for 20 minutes.viously described [34]. Ten micrograms of total RNA
were then fractionated on 1.6% agarose gel and blotted Overexpression of adenovirally encoded IjB in
HUVEC. Subconfluent HUVEC were incubated with re-onto synthetic membranes (Zeta-probe; Bio-Rad, Rich-
mond, CA, USA). IL-8 and MCP-1 cDNA probes were combinant adenovirus coding for IB (a kind gift from
Dr. R. de Martin, Department of Vascular Biology andkindly provided by Dr. K. Matsushima (Laboratory of
Molecular Immunoregulation, National Cancer Insti- Thrombosis Research, University of Vienna, Vienna,
Austria) [29] or with a control adenovirus (Ad null con-tute, Bethesda, MD, USA). IL-8 mRNA was detected
by using a 300 base pair (bp) fragment of human IL-8 trol) at a multiplicity of infection (MOI) of 300 in M-199
without serum for three hours at 37C. The adenoviruscDNA. For MCP-1 a 345 bp fragment of human MCP-1
cDNA was used to detect the MCP-1 mRNA transcript. was washed off and cells were maintained in fresh growth
medium for 24 hours. Then HUVEC were exposed toThe probes were labeled with -32P dCTP by random-
primed method as previously described [35]. Hybridiza- Stx-2 (25 or 50 pmol/L) for additional 24 hours and
processed for IL-8 and MCP-1 mRNA expression (North-tion was performed overnight at 60C in 0.5 mol/L
Na2HPO4, pH 7.2, 7% SDS. Filters were washed twice ern blot) or leukocyte adhesion and transmigration ex-
periments.for 30 minutes with 40 mmol/L Na2HPO4, pH 7.2, 5%
SDS and two times for 10 minutes with 40 mmol/L
Statistical analysisNa2HPO4, pH 7.2, 1% SDS at 65C. Membranes were
subsequently probed with a glyceraldehyde-3-phosphate Results are expressed as mean 
 SE. Data were ana-
lyzed by analysis of variance (ANOVA) followed bydehydrogenase (GAPDH) cDNA, taken as internal stan-
dard of equal loading of the samples on the membrane. Tukey’s test for multiple comparisons or by the nonpara-
metric Kruskal-Wallis test for multiple comparisons. Sta-IL-8 and MCP-1 mRNA optical density was normal-
ized to that of the constituently released GAPDH gene tistical significance level was defined as P 	 0.05.
expression.
RESULTSPreparation of nuclear extracts
Stx-2 promotes leukocyte adhesion andNuclear extracts were prepared from HUVEC using
transmigration via up-regulation of IL-8the NE-PER Nuclear and Cytoplasmic Extraction Re-
and MCP-1 mRNA in HUVECagents Kit (Pierce/Celbio, Pero, Italy) according to the
manufacturer’s instructions. To minimize proteolysis, all We previously showed that Stx-1 induced leukocyte ad-
hesion to HUVEC under flow conditions [17]. Here,buffers contained protease inhibitor cocktail (Protease
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activated and change shape (Fig. 2A) before transmigrat-
ing through the subendothelium (Fig. 2B).
The ability of Stx-2 to modulate the endothelial ex-
pression of IL-8 and MCP-1 was assessed by Northern
blot experiments. The expression of IL-8 mRNA in-
creased over control after 6 hour exposure of HUVEC
to different concentrations of Stx-2 (Fig. 3A). Actually,
Stx-2 at 25 pmol/L, the same concentration used in the
adhesion experiments, promoted a twofold increase in
IL-8 transcript levels as compared to control cells (P 	
0.01), which was further enhanced by 50 pmol/L and
maintained elevated by the highest concentration of 1
nmol/L (2.6- and 2.4-fold increase, P 	 0.01). As shown
in Figure 3B, up-regulation of MCP-1 mRNA also was
induced by Stx-2 at all the concentrations studied (P 	
0.01 vs. control).
To study the functional role of these chemokines in
Stx-2–induced leukocyte adhesion and transmigration,
HUVEC exposed for 24 hours to 25 pmol/L Stx-2 were
treated with anti-IL-8 and anti-MCP-1 antibodies before
performing the adhesion assay. Functional blocking of
IL-8 significantly reduced the number of adhering leuko-
Fig. 1. Leukocyte adhesion (A) and transmigration (B) in human um-
cytes on Stx-2 treated HUVEC under flow conditionsbilical endothelial vein cells (HUVEC) treated with Shiga toxin-2 (Stx-2)
under flow condition (1.5 dynes/cm2). Endothelial cells were exposed (Stx-2, 164 
 12 vs. Stx-2  anti-IL-8 Ab, 40 
 2 leuko-
to control medium, Stx-2 (25 pmol/L, 24 hours) or tumor necrosis factor- cytes/mm2, P 	 0.01; Fig. 4). A remarkable inhibitory
(TNF-; 100 U/mL, 24 hours) as positive control. At the end of perfu-
effect also was obtained by treating HUVEC with thesion, the number of adherent and transmigrated leukocytes were quanti-
fied by digital analysis of videotapes of each experiment (N  9 experi- anti-MCP-1 Ab (Stx-2  anti-MCP-1 Ab, 80 
 7 leuko-
ments). Data are expressed as mean 
 SE. *P 	 0.01 vs. control. cytes/mm2, P 	 0.01; Fig. 4). As a consequence of the
reduced leukocyte adhesion, the number of transmi-
grated cells through the endothelial monolayer was sig-
nificantly lessened by both anti-IL-8 and anti-MCP-1we investigated the effect of Stx-2 on subendothelial
antibodies (Stx-2, 29 
 1 vs. Stx-2  anti-IL-8 Ab, 3 
 1leukocyte transmigration and the role of IL-8 and MCP-1
and Stx-2  anti-MCP-1 Ab, 6 
 1 leukocytes/mm2; P 	expressed by the endothelium in these adhesive events.
0.01; Fig. 4). Treatment with the corresponding irrele-Consistent with our prior study [17], Stx-2 at a subtoxic
vant antibodies did not affect leukocyte adhesion (ir-concentration (25 pmol/L, 24 h) significantly (P 	 0.01)
relevant rabbit IgG, 154 
 6 and irrelevant mouse IgG,increased the number of leukocytes that adhered on
157 
 13 leukocytes/mm2 for anti-IL-8 and MCP-1 Abs,HUVEC with respect to unstimulated cells (175 
 14
respectively) and transmigration induced by Stx-2 (ir-vs. 32 
 6 leukocytes/mm2; Fig. 1). This response was
relevant rabbit IgG, 30 
 3 and irrelevant mouse IgG,similar to that elicited by TNF-, one of the most potent
33 
 4 leukocytes/mm2 for anti- IL-8 and MCP-1 Abs,inducers of endothelial cell adhesive properties, used as
respectively).positive control (244 
 34 leukocytes/mm2). As shown
By analyzing the leukocyte populations that adheredin Figure 1, a massive transmigration of leukocytes across
to the Stx-treated endothelial cells after flow exposure,the endothelium was elicited by Stx-2 (Stx-2, 33 
 3 vs.
we identified polymorphonuclear cells as the major sub-control, 2 
 1 leukocytes/mm2, P 	 0.01), which was as
sets of adherent leukocytes (80.2
 4.2%). Mononuclearintense as that observed after cell activation with TNF-
cells (19.3
 4.2%) also were present. Anti-IL-8 antibody(39 
 2 leukocytes/mm2).
reduced by 81.8
 2.8% and 69.5
 5.5% the adhesion ofScanning electron micrographs of Stx-2 treated
polymorphonuclear and mononuclear cells, respectively.HUVEC illustrate adherent and transmigrated leuko-
cytes at different stages of activation in a sequence that As expected, a more pronounced inhibitory effect on
adherent mononuclear cells was observed after treat-resembles the multistep model of in vivo leukocyte-endo-
thelial cell recognition and extravasation (Fig. 2) [23, 37]. ment with anti-MCP-1 antibody (% inhibition, mononu-
clear cells, 90.2
 1.5 and polymorphonuclear cells, 27
As the initial step, some leukocytes attach to the endothe-
lium through their membrane projections, others become 3.4%).
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Fig. 2. Scanning electron micrograph of
adherent and transmigrated leukocytes in
HUVEC challenged with Stx-2. Micrographs
show adherent (A) and transmigrated (B) leu-
kocytes at different stages of activation in
HUVEC treated with Stx-2 (25 pmol/L, 24 h).
Fig. 3. Expression of interleukin-8 (IL-8; A)
and monocyte chemoattractant protein-1
(MCP-1; B) mRNA in HUVEC exposed to
Stx-2. (Top) Northern blot experiments were
performed using total RNA isolated after a
6-hour period of culture with medium alone
(control) or Stx-2 (25 pmol/L, 50 pmol/L and
1 nmol/L). Data shown are representative of
N  5 experiments. (Bottom) Densitometric
analysis of autoradiographic signals for IL-8
and MCP-1. The optical density of the autora-
diographic signals was quantified and calcu-
lated as the ratio of IL-8 or MCP-1 to GAPDH
mRNA. Results (mean 
 SE) are expressed
as the fold increase over control (considered
as 1) in densitometric arbitrary units. *P 	
0.01 vs. control.
Fig. 4. Effect of anti-IL-8 or anti-MCP-1 an-
tibodies on Stx-2 induced leukocyte adhesion
and transmigration under flow. Before the ad-
hesion assay, HUVEC treated for 24 hours
with Stx-2 (25 pmol/L) were exposed for 20
minutes to anti-IL-8 or anti-MCP-1 antibod-
ies. At the end of perfusion, the number of
adherent and transmigrated leukocytes were
quantified. Data are mean
SE (N 7 experi-
ments). *P 	 0.01 vs. control, P 	 0.01 vs.
Stx-2, #P	 0.05 vs. Stx-2anti IL-8 antibody.
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confirmed in competition experiments by the ability of
excess unlabeled (cold) NF-B oligonucleotide to inhibit
binding. Moreover, when excess unlabeled TRE oligo-
nucleotide was used as irrelevant probe, it did not affect
the binding of the specific B probe to nuclear proteins.
Since NF-B complexes may constitute a variety of
different homo- and heterodimers, the subunit composi-
tions of the Stx-induced DNA complexes were analyzed
by supershift assay (Fig. 6B). Rabbit polyclonal antisera
specific for p65, p50, cRel, RelB, and p52 were added
to nuclear extracts of Stx-treated HUVEC. The upper
band, complex I consisted of p65/p50 heterodimer, since
pre-incubation of the cells with anti-p50 antibody consis-
tently reduced the intensity of the complex, while anti-
p65 antibody abolished it. Both antibodies caused further
gel retardation (supershift). Complex II was inhibited
by anti-p50 antibody, suggesting that the complex II rep-
Fig. 5. Stx-2 induces leukocyte adhesion on glomerular endothelial
resented p50/p50 homodimer.cells (GEC) under flow. Effect of anti-IL-8 or anti-MCP-1 antibodies.
GEC were treated for 24 hours with control medium or Stx-2 (25
pmol/L), and then cells were exposed or not to anti-IL-8 or anti-MCP-1 Adenoviral overexpression of IB inhibits
antibodies for 20 minutes. At the end of perfusion, the number of Stx-induced IL-8 and MCP-1 mRNA and
adherent leukocytes were quantified. Data are mean 
 SE (N  3
leukocyte adhesion and transmigrationexperiments). *P 	 0.01 vs. control, P 	 0.01 vs. Stx-2.
We explored the possibility that up-regulation of en-
dothelial IL-8 and MCP-1 mRNA in response to Stx-2
was dependent on NF-B. Since NF-B activity is regu-
Stx-2 enhances leukocyte adhesion and lated by IB inhibitor proteins, which sequester NF-B
transmigration in glomerular endothelial cells into cytoplasm and avoid its translocation to the nucleus,
through an IL-8 and MCP-1 dependent pathway overexpression of IB was achieved through infection
In selected experiments performed in human glomeru- of HUVEC with a replication-deficient recombinant
lar endothelial cells, Stx-2 (25 pmol/L, 24 h) promoted adenovirus encoding IB. In non-stimulated cells, com-
a massive adhesion of leukocytes on the endothelium plex formation with IB inhibited constitutive expres-
under flow, at a comparable extent than HUVEC. As sion of IL-8 and MCP-1. Moreover, delivery of IB
shown in Figure 5, on average 185 
 16 leukocytes/mm2 resulted in a remarkable reduction of Stx-induced IL-8
adhered to Stx-2 treated GEC compared with 36 
 10 and MCP-1 mRNA transcript levels (Fig. 7), thus indicat-
leukocytes/mm2 to unstimulated cells (P 	 0.01). Anti- ing that activated NF-B is responsible for chemokine
IL-8 and anti-MCP-1 antibodies significantly limited the up-regulation.
number of adherent leukocytes (Stx-2  anti-IL-8 Ab, The consequence of inhibiting NF-B by adenovirus-
57 
 12; Stx-2  anti-MCP-1 Ab, 77 
 14 leukocytes/ mediated gene transfer of IB was investigated further
mm2; P 	 0.01 vs. Stx-2). Similar to what was observed in the adhesion assay. As shown in Figure 8, leukocyte
in HUVEC, leukocyte adhesion induced by Stx-2 on GEC adhesion induced by Stx-2 was reduced by 60% on
was followed by transendothelial migration, which was HUVEC overexpressing IB versus noninfected cells
reduced by the functional blockade of IL-8 and MCP-1. (P 	 0.05). A similar inhibition (70%; P 	 0.05) was
observed in leukocyte transmigration. No difference wasStx-2 activates the transcription factor NF-B
observed in unstimulated cells infected with the control
Based on the evidence that both the IL-8 and MCP-1 adenovirus (Ad null control) with respect to unstimu-
genes have a consensus sequence in their promoter for lated cells transfected with rAd IB.
the transcription factor NF-B [38, 39], we studied the
effect of Stx-2 on NF-B activation. As shown in Fig-
DISCUSSIONure 6, the nuclear extracts from control cells displayed
two constitutive bands: an upper complex (complex I) Endothelial dysfunction is crucial to the development
of microvascular lesions in HUS [5, 6], and increasingand a faster migrating lower complex (complex II).
Treatment of HUVEC for one hour with increasing con- evidence suggests that Shiga toxins, by favoring interac-
tion of endothelial cells with leukocytes [17, 18] andcentrations of Stx-2 elicited a substantial rise in NF-B
binding activity that was already evident at 25 pmol/L platelets [40], serve to amplify and extend the injury at
renal level. As a follow-up of previous studies [17], here(Fig. 6A). The specificity of the binding reaction was
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Fig. 6. Stx-2 activates the transcription factor
NF-B. (A) EMSA for NF-B activity was
performed in nuclear extracts from HUVEC
exposed for 1 hour to Stx-2 (25 pmol/L, 50
pmol/L and 1 nmol/L). Complexes I and II de-
note the inducible B specific DNA-protein
complexes. A 100-fold molar excess unlabeled
(cold) or an unlabeled nonspecific oligonucle-
otide (irrelevant probe) was added to nuclear
extracts from HUVEC treated with Stx-2 (50
pmol/L). The results shown are representative
of three independent experiments employing
different nuclear extracts. (B) Subunit compo-
sition of NF-B activated by Stx-2. Nuclear
extracts from HUVEC treated with Stx-2 (50
pmol/L, 1 hour) were incubated with antibod-
ies against p65, p50, cRel, RelB and p52 sub-
units. Antibody supershifts produced by bind-
ing of the antibody to the DNA-protein
complex are indicated.
Fig. 7. Expression of IL-8 and MCP-1
mRNA induced by Stx-2 is inhibited by adeno-
virus-mediated gene transfer of IB. Endo-
thelial cells were left untreated or infected
with rAd.IkB for 3 hours, then cells were
exposed to medium alone or to Stx-2 (50
pmol/L, 6 hours). Results shown are represen-
tative of N  3 Northern blot experiments.
Fig. 8. Leukocyte adhesion and transmigra-
tion induced by Stx-2 are regulated by endo-
thelial activation of NF-B dependent genes.
Endothelial cells were left untreated or in-
fected with rAd.IB for 3 hours, then cells
were exposed to medium alone (control; )
or to Stx-2 (25 pmol/L, 24 h; Stx-2; ). At
the end of incubation, HUVEC were perfused
with total leukocyte suspension and the num-
ber of leukocytes that adhered and transmi-
grated were quantified. Data are expressed as
mean 
 SE (N  3 experiments). P 	 0.05
vs. control; *P 	 0.05 vs. non infected Stx-2.
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we characterized the adhesive phenomena triggered by in the urine of HUS patients during the acute phase of
Stx-2, studying the adhesion and transmigration of leu- the disease and returned to normal in remission [21, 22].
kocytes in human endothelial cells exposed to Stx-2, Here we found that IL-8 and MCP-1 mRNA expression
under flow conditions. We found that sub-toxic concen- was increased after a six hour exposure of endothelial
trations of Stx-2 [17, 40] induced a significant increase cells to Stx-2. That both chemokines can actually have a
in the number of leukocytes adhering to HUVEC, fol- functional role in the adhesive process triggered by Stx-2
lowed by a massive transmigration through the endothe- rests on the evidence that specific antibodies against IL-8
lial monolayer. The adhesion elicited by Stx-2, that is, and MCP-1 limited to a remarkable extent the leukocyte
sixfold increase over control, was comparable to that of adhesion and subendothelial transmigration in HUVEC
TNF- (8-fold increase), one of the most potent inducers as well as glomerular endothelial cells treated with Stx-2.
of leukocyte-endothelial cell adhesiveness known to Of note, anti-IL-8 antibody had a more pronounced in-
date. The major subset of leukocytes that adhered on Stx- hibitory effect as compared to anti-MCP-1 antibody. Ac-
treated endothelial cells consisted of polymorphonuclear tually, anti-IL-8 antibody markedly decreased both ad-
cells (80%) while mononuclear cells represented 20%. herent polymorphonuclear and mononuclear cells (82%
A relevant finding was that exposure to Stx-2 under and 70% inhibition, respectively). This finding is consis-
flow induced massive adhesion and transmigration of tent with recent data that IL-8, thought to act predomi-
leukocytes in glomerular endothelial cells, to a similar nantly on neutrophils, instead had the ability to promote
extent as that for HUVEC. Thus, both types of endothe- the adhesion of monocytes to vascular endothelium un-
lial cells at confluence showed a similar sensitivity to a der flow [44]. Anti-MCP-1 antibody almost completely
Stx-2 concentration that did not affect cell viability, but abolished mononuclear cell adhesion to Stx-treated en-
stimulated intracellular pathways resulting in the en- dothelium (90% inhibition) and decreased polymorpho-
hanced adhesive phenomena. nuclear cells by 27%.
Contrasting data are available in the literature regard- Chemokines trigger adhesion and migration of distinct
ing the differential sensitivity of HUVEC and renal mi- leukocyte subsets either as soluble chemoattractants or
crovascular endothelial cells to Stxs. Confluent HUVEC as immobilized molecules bound to heparan sulfate pro-
were little susceptible to the cytotoxic effect of Stx-1, teoglycans of the endothelial surface of post-capillary
unless they were pretreated with cytokines that up-regu- venules and small veins [23, 37, 45]. In an in vitro flow-
late Gb3 receptors [13]. Renal microvascular endothelial based adhesion assay and video microscopy, exposure
cells had greater sensitivity to the toxic effects of Stx-1 of endothelial cells to hypoxia and re-oxygenation re-
than HUVEC, because they constitutively expressed 50- sulted in neutrophil attachment and migration due to
times more Stx receptor [41]. At variance, purified glo-
the action of IL-8 expressed on the endothelium, as docu-
merular endothelial cells, such as those used in our study,
mented by the inhibitory effect of an anti-IL-8 antibodysimilarly to HUVEC, responded to Stx and underwent
[46]. In a model of monocytes rolling on adenovirallycell death and inhibition of protein synthesis only when
E-selectin transduced endothelial cells under flow, MCP-1they were sub-confluent. At confluence, they instead re-
and IL-8 caused firm adhesion of monocytes to the endo-quired pre-exposure to cytokines [15].
thelium through the activation of leukocyte integrins [44].The concept that leukocytes are crucial to the patho-
Since IL-8 and MCP-1 genes have in their promotergenesis of microvascular lesions in Stx-associated HUS
a consensus sequence for the transcription factor NF-Bis based on evidence that the number of polymorphonu-
[38, 39], we verified whether NF-B activation could beclear cells is elevated and may be a predictive factor for
a candidate pathway of Stx-2-induced chemokine expres-the outcome of the disease [42]. Ultrastructural studies
sion in endothelial cells. NF-B belongs to Rel familyshowed polymorphonuclear and mononuclear cell infil-
comprising different members, including RelA (p65),trates in the glomeruli of patients with sporadic HUS
cRel, RelB, p50 and p52, which form homo- or hetero-[20, 21]. In addition, during the acute phase of the disease
dimers with different affinities for variants of a decamericneutrophils are activated [19], become more adhesive
consensus binding site [25, 47]. NF-B exists in an inac-than normal, and damage the endothelium by producing
tive form in the cytoplasm of cells bound to the inhibitoryelastase [18] and superoxide [43]. More recently, in vitro
IB subunit and upon activation by different stimuliand in vivo studies pointed to an additional role of neu-
NF-B translocates into the nucleus for binding to DNAtrophils as the cells responsible for binding and transfer
motifs in gene promoters [25]. Here we found that expo-of Stx from intestine to the kidney endothelium [8, 9].
sure of endothelial cells to Stx-2 increased NF-B-DNAIn the present study we sought to understand cellular
binding activity and that the protein subunits involvedand molecular mechanisms responsible for the recruit-
were p65/p50 heterodimer and p50/p50 homodimer.ment of leukocytes into the kidney of HUS, which have
These results are in line with a previous study showingnever been clarified.
Interleukin-8 and MCP-1 were significantly increased that treatment of cultured human monocytes with Stx-1
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